Eli Lilly and Co (LLY.NO)
34.30
+0.44
(+1.30%)
CAD |
NEO |
Sep 19, 15:58
Eli Lilly Revenue (Quarterly): 15.47B for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 15.47B |
| March 31, 2024 | 11.82B |
| December 31, 2023 | 12.73B |
| September 30, 2023 | 12.75B |
| June 30, 2023 | 11.17B |
| March 31, 2023 | 9.416B |
| December 31, 2022 | 9.874B |
| September 30, 2022 | 9.053B |
| June 30, 2022 | 8.272B |
| March 31, 2022 | 9.890B |
| December 31, 2021 | 10.08B |
| September 30, 2021 | 8.527B |
| June 30, 2021 | 8.275B |
| March 31, 2021 | 8.613B |
| December 31, 2020 | 9.692B |
| September 30, 2020 | 7.644B |
| June 30, 2020 | 7.622B |
| March 31, 2020 | 7.861B |
| December 31, 2019 | 8.071B |
| September 30, 2019 | 7.232B |
| June 30, 2019 | 7.541B |
| March 31, 2019 | 6.771B |
| December 31, 2018 | 7.453B |
| September 30, 2018 | 6.937B |
| June 30, 2018 | 7.206B |
| Date | Value |
|---|---|
| March 31, 2018 | 6.270B |
| December 31, 2017 | 4.150B |
| September 30, 2017 | 7.093B |
| June 30, 2017 | 7.835B |
| March 31, 2017 | 6.922B |
| December 31, 2016 | 7.686B |
| September 30, 2016 | 6.770B |
| June 30, 2016 | 6.964B |
| March 31, 2016 | 6.682B |
| December 31, 2015 | 7.181B |
| September 30, 2015 | 6.489B |
| June 30, 2015 | 6.121B |
| March 31, 2015 | 5.753B |
| December 31, 2014 | 5.822B |
| September 30, 2014 | 5.308B |
| June 30, 2014 | 5.383B |
| March 31, 2014 | 5.162B |
| December 31, 2013 | 6.097B |
| September 30, 2013 | 5.995B |
| June 30, 2013 | 6.066B |
| March 31, 2013 | 5.644B |
| December 31, 2012 | 5.905B |
| September 30, 2012 | 5.421B |
| June 30, 2012 | 5.656B |
| March 31, 2012 | 5.610B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
7.232B
Minimum
Sep 2019
15.47B
Maximum
Jun 2024
9.703B
Average
9.235B
Median
Revenue (Quarterly) Benchmarks
| Planet 13 Holdings Inc | 42.54M |
| Trulieve Cannabis Corp | 415.23M |
| The Hempshire Group Inc | 0.066M |
| Ascend Wellness Holdings Inc | 141.54M |
| Bright Minds Biosciences Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.060B |
| Total Expenses (Quarterly) | 9.421B |
| EPS Diluted (Quarterly) | 0.1224 |
| Enterprise Value | 1.153T |
| Gross Profit Margin (Quarterly) | 80.80% |
| Profit Margin (Quarterly) | 26.25% |
| Earnings Yield | 0.88% |
| Operating Earnings Yield | 1.69% |
| Normalized Earnings Yield | 1.308 |